Kymera Therapeutics KYMR Return on invested capital

Return on invested capital at other companies

PfizerPFE

6%—

Johnson & JohnsonJNJ

19.2%+1.3pp

Regeneron PharmaceuticalsREGN

10.3%-1.5pp

Nurix Therapeutics, Inc.NRIX

-89.5%+48.4pp

ArvinasARVN

-56.5%-101pp

Monte Rosa Therapeutics, Inc.GLUE

-53.9%—

FAQ

What is Kymera Therapeutics's return on invested capital?

Kymera Therapeutics (KYMR) reported return on invested capital of -32% in Q2 2026.

How has Kymera Therapeutics's return on invested capital changed year-over-year?

Kymera Therapeutics's return on invested capital increased by 26.6% year-over-year, from -43.6% to -32%.

What is the long-term trend for Kymera Therapeutics's return on invested capital?

Over 4 years (2021 to 2025), Kymera Therapeutics's return on invested capital has grown at a 3.7% compound annual growth rate (CAGR), from -28.6% to -33.1%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.